Details for Patent: 7,964,647
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,964,647 protect, and when does it expire?
Patent 7,964,647 protects COLCRYS and is included in one NDA.
Summary for Patent: 7,964,647
| Title: | Colchicine compositions and methods |
| Abstract: | Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. |
| Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
| Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
| Application Number: | 12/407,980 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,964,647 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,964,647
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING GOUT FLARES | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
